Stratec SE (0RAR.L)
EUR 23.01
(-0.01%)
EUR 23.01
(-0.01%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 13.06 Million EUR | -55.29% |
| 2022 | 29.22 Million EUR | -26.87% |
| 2021 | 39.95 Million EUR | 58.72% |
| 2020 | 25.17 Million EUR | 74.34% |
| 2019 | 14.44 Million EUR | 61.0% |
| 2018 | 8.96 Million EUR | -65.01% |
| 2017 | 25.63 Million EUR | 30.98% |
| 2016 | 19.57 Million EUR | -11.37% |
| 2015 | 22.08 Million EUR | 11.72% |
| 2014 | 19.76 Million EUR | 27.72% |
| 2013 | 15.47 Million EUR | 10.77% |
| 2012 | 13.97 Million EUR | -8.56% |
| 2011 | 15.28 Million EUR | 17.2% |
| 2010 | 13.03 Million EUR | 11.7% |
| 2009 | 11.67 Million EUR | 16.84% |
| 2008 | 9.99 Million EUR | 0.0% |
| 2007 | - EUR | 0.0% |
| 2006 | - EUR | -100.0% |
| 2005 | 4.41 Million EUR | 58.84% |
| 2004 | 2.77 Million EUR | 64.95% |
| 2003 | 1.68 Million EUR | 51.58% |
| 2002 | 1.11 Million EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 3.47 Million EUR | 677.4% |
| 2024 Q3 | 549 Thousand EUR | -84.2% |
| 2024 Q1 | 447 Thousand EUR | -91.93% |
| 2023 Q2 | 1.04 Million EUR | -23.67% |
| 2023 Q1 | 1.36 Million EUR | -69.6% |
| 2023 FY | 13.06 Million EUR | -55.29% |
| 2023 Q4 | 5.54 Million EUR | 8.39% |
| 2023 Q3 | 5.11 Million EUR | 389.19% |
| 2022 Q3 | 12.11 Million EUR | 745.57% |
| 2022 FY | 29.22 Million EUR | -26.87% |
| 2022 Q4 | 4.5 Million EUR | -62.83% |
| 2022 Q1 | 11.16 Million EUR | 209.39% |
| 2022 Q2 | 1.43 Million EUR | -87.17% |
| 2021 Q2 | 13.61 Million EUR | 17.86% |
| 2021 FY | 39.95 Million EUR | 58.72% |
| 2021 Q3 | 11.18 Million EUR | -17.82% |
| 2021 Q1 | 11.54 Million EUR | 14.8% |
| 2021 Q4 | 3.61 Million EUR | -67.73% |
| 2020 Q3 | 6.48 Million EUR | 3.68% |
| 2020 FY | 25.17 Million EUR | 74.34% |
| 2020 Q4 | 10.06 Million EUR | 55.15% |
| 2020 Q1 | 2.37 Million EUR | -68.5% |
| 2020 Q2 | 6.25 Million EUR | 163.22% |
| 2019 Q3 | 3 Million EUR | -28.49% |
| 2019 Q2 | 4.2 Million EUR | 1430.7% |
| 2019 FY | 14.44 Million EUR | 61.0% |
| 2019 Q4 | 7.54 Million EUR | 150.88% |
| 2019 Q1 | -316 Thousand EUR | -109.52% |
| 2018 FY | 8.96 Million EUR | -65.01% |
| 2018 Q1 | 922 Thousand EUR | -90.7% |
| 2018 Q2 | 1.7 Million EUR | 84.49% |
| 2018 Q3 | 3.02 Million EUR | 77.84% |
| 2018 Q4 | 3.32 Million EUR | 9.79% |
| 2017 Q4 | 9.9 Million EUR | 4.18% |
| 2017 Q3 | 9.51 Million EUR | 240.29% |
| 2017 Q2 | 2.79 Million EUR | -18.27% |
| 2017 Q1 | 3.42 Million EUR | -70.74% |
| 2017 FY | 25.63 Million EUR | 30.98% |
| 2016 Q1 | 3.42 Million EUR | -44.49% |
| 2016 FY | 19.57 Million EUR | -11.37% |
| 2016 Q2 | 2.97 Million EUR | -13.11% |
| 2016 Q3 | 1.48 Million EUR | -50.15% |
| 2016 Q4 | 11.68 Million EUR | 688.2% |
| 2015 Q1 | 4.73 Million EUR | -15.65% |
| 2015 FY | 22.08 Million EUR | 11.72% |
| 2015 Q4 | 6.16 Million EUR | 0.97% |
| 2015 Q3 | 6.1 Million EUR | 20.54% |
| 2015 Q2 | 5.06 Million EUR | 6.94% |
| 2014 Q2 | 5.26 Million EUR | 43.76% |
| 2014 Q3 | 5.22 Million EUR | -0.7% |
| 2014 FY | 19.76 Million EUR | 27.72% |
| 2014 Q1 | 3.66 Million EUR | -26.2% |
| 2014 Q4 | 5.61 Million EUR | 7.5% |
| 2013 Q3 | 3.63 Million EUR | 24.1% |
| 2013 Q1 | 3.61 Million EUR | 16.41% |
| 2013 Q2 | 2.92 Million EUR | -19.15% |
| 2013 FY | 15.47 Million EUR | 10.77% |
| 2013 Q4 | 4.96 Million EUR | 36.67% |
| 2012 Q3 | 3.51 Million EUR | -10.22% |
| 2012 Q1 | 3.43 Million EUR | -36.8% |
| 2012 Q2 | 3.91 Million EUR | 13.78% |
| 2012 Q4 | 3.1 Million EUR | -11.53% |
| 2012 FY | 13.97 Million EUR | -8.56% |
| 2011 FY | 15.28 Million EUR | 17.2% |
| 2011 Q2 | 4.01 Million EUR | 34.87% |
| 2011 Q4 | 5.44 Million EUR | 95.04% |
| 2011 Q3 | 2.79 Million EUR | -30.44% |
| 2011 Q1 | 2.97 Million EUR | -67.82% |
| 2010 Q3 | 3.79 Million EUR | 22.2% |
| 2010 FY | 13.03 Million EUR | 11.7% |
| 2010 Q4 | 9.24 Million EUR | 143.32% |
| 2010 Q1 | 2.87 Million EUR | -67.33% |
| 2010 Q2 | 3.1 Million EUR | 8.18% |
| 2009 Q3 | -2.01 Million EUR | -173.35% |
| 2009 Q2 | 2.74 Million EUR | 26.3% |
| 2009 Q4 | 8.79 Million EUR | 536.46% |
| 2009 FY | 11.67 Million EUR | 16.84% |
| 2009 Q1 | 2.17 Million EUR | 0.0% |
| 2008 FY | 9.99 Million EUR | 0.0% |
| 2007 FY | - EUR | 0.0% |
| 2006 FY | - EUR | -100.0% |
| 2005 FY | 4.41 Million EUR | 58.84% |
| 2004 FY | 2.77 Million EUR | 64.95% |
| 2003 FY | 1.68 Million EUR | 51.58% |
| 2002 FY | 1.11 Million EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Cegedim SA | -7.4 Million EUR | 276.414% |
| Guerbet SA | 23.86 Million EUR | 45.248% |
| Nexus AG | 24.03 Million EUR | 45.624% |
| Bastide Le Confort Médical SA | -900 Thousand EUR | 1551.889% |
| Revenio Group Oyj | 19.1 Million EUR | 31.619% |
| Drägerwerk AG & Co. KGaA | 110.43 Million EUR | 88.167% |
| Sartorius Aktiengesellschaft | 205.2 Million EUR | 93.632% |
| LNA Santé SA | 23.4 Million EUR | 44.18% |
| Siemens Healthineers AG | 1.94 Billion EUR | 99.327% |
| Medios AG | 18.81 Million EUR | 30.532% |
| Equasens Société anonyme | 47.04 Million EUR | 72.226% |